112 related articles for article (PubMed ID: 15577203)
1. Interindividual variability in 2-hydroxylation, 3-sulfation, and 3-glucuronidation of ethynylestradiol in human liver.
Shiraga T; Niwa T; Ohno Y; Kagayama A
Biol Pharm Bull; 2004 Dec; 27(12):1900-6. PubMed ID: 15577203
[TBL] [Abstract][Full Text] [Related]
2. Interindividual variability in the glucuronidation and sulphation of ethinyloestradiol in human liver.
Temellini A; Giuliani L; Pacifici GM
Br J Clin Pharmacol; 1991 Jun; 31(6):661-4. PubMed ID: 1907838
[TBL] [Abstract][Full Text] [Related]
3. Study on effects of p-phenylbenzoic acid on change of sulfation and glucuronidation in rats.
Nanbo A; Nanbo T
Biol Pharm Bull; 2002 May; 25(5):686-9. PubMed ID: 12033518
[TBL] [Abstract][Full Text] [Related]
4. Studies on the interactions between drugs and estrogen. III. Inhibitory effects of 29 drugs reported to induce gynecomastia on the glucuronidation of estradiol.
Satoh T; Tomikawa Y; Takanashi K; Itoh S; Itoh S; Yoshizawa I
Biol Pharm Bull; 2004 Nov; 27(11):1844-9. PubMed ID: 15516735
[TBL] [Abstract][Full Text] [Related]
5. Interindividual variability in 5-Fluorouracil metabolism and procainamide N-acetylation in human liver cytosol.
Niwa T; Shiraga T; Ohno Y; Kagayama A
Biol Pharm Bull; 2005 Jun; 28(6):1071-4. PubMed ID: 15930747
[TBL] [Abstract][Full Text] [Related]
6. Phase II metabolism in human skin: skin explants show full coverage for glucuronidation, sulfation, N-acetylation, catechol methylation, and glutathione conjugation.
Manevski N; Swart P; Balavenkatraman KK; Bertschi B; Camenisch G; Kretz O; Schiller H; Walles M; Ling B; Wettstein R; Schaefer DJ; Itin P; Ashton-Chess J; Pognan F; Wolf A; Litherland K
Drug Metab Dispos; 2015 Jan; 43(1):126-39. PubMed ID: 25339109
[TBL] [Abstract][Full Text] [Related]
7. Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10.
Watanabe Y; Nakajima M; Yokoi T
Drug Metab Dispos; 2002 Dec; 30(12):1462-9. PubMed ID: 12433820
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of biliary and urinary 2-hydroxylated metabolites of [6,7-3H]17 alpha-ethynylestradiol in women.
Maggs JL; Park BK
Contraception; 1985 Aug; 32(2):173-82. PubMed ID: 4075792
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the N-glucuronidation pathway to the overall in vitro metabolic clearance of midazolam in humans.
Klieber S; Hugla S; Ngo R; Arabeyre-Fabre C; Meunier V; Sadoun F; Fedeli O; Rival M; Bourrie M; Guillou F; Maurel P; Fabre G
Drug Metab Dispos; 2008 May; 36(5):851-62. PubMed ID: 18256203
[TBL] [Abstract][Full Text] [Related]
10. Sulphation and glucuronidation of ethinyloestradiol in human liver in vitro.
Pacifici GM; Back DJ
J Steroid Biochem; 1988 Sep; 31(3):345-9. PubMed ID: 3138501
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of 17 alpha-ethynylestradiol in humans.
Guengerich FP
Life Sci; 1990; 47(22):1981-8. PubMed ID: 2273938
[TBL] [Abstract][Full Text] [Related]
12. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T
J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
[TBL] [Abstract][Full Text] [Related]
13. Prediction of total propofol clearance based on enzyme activities in microsomes from human kidney and liver.
Al-Jahdari WS; Yamamoto K; Hiraoka H; Nakamura K; Goto F; Horiuchi R
Eur J Clin Pharmacol; 2006 Jul; 62(7):527-33. PubMed ID: 16763826
[TBL] [Abstract][Full Text] [Related]
14. Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes.
Yamanaka H; Nakajima M; Katoh M; Kanoh A; Tamura O; Ishibashi H; Yokoi T
Drug Metab Dispos; 2005 Jan; 33(1):23-30. PubMed ID: 15470160
[TBL] [Abstract][Full Text] [Related]
15. Sulfation and glucuronidation of benzo[a]pyrene-7,8-dihydrodiol in intestinal mucosa of channel catfish (Ictalurus punctatus).
van den Hurk P; James MO
Mar Environ Res; 2000; 50(1-5):11-5. PubMed ID: 11460675
[TBL] [Abstract][Full Text] [Related]
16. N-Glucuronidation of the antiepileptic drug retigabine: results from studies with human volunteers, heterologously expressed human UGTs, human liver, kidney, and liver microsomal membranes of Crigler-Najjar type II.
Borlak J; Gasparic A; Locher M; Schupke H; Hermann R
Metabolism; 2006 Jun; 55(6):711-21. PubMed ID: 16713428
[TBL] [Abstract][Full Text] [Related]
17. Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1.
Watanabe Y; Nakajima M; Ohashi N; Kume T; Yokoi T
Drug Metab Dispos; 2003 May; 31(5):589-95. PubMed ID: 12695347
[TBL] [Abstract][Full Text] [Related]
18. UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver.
Court MH; Hao Q; Krishnaswamy S; Bekaii-Saab T; Al-Rohaimi A; von Moltke LL; Greenblatt DJ
J Pharmacol Exp Ther; 2004 Aug; 310(2):656-65. PubMed ID: 15044558
[TBL] [Abstract][Full Text] [Related]
19. Role of rat cytochromes P450 in the oxidation of 17α-ethinylestradiol.
Bořek-Dohalská L; Valášková P; Černá V; Stiborová M
Environ Toxicol Pharmacol; 2014 Nov; 38(3):852-60. PubMed ID: 25461545
[TBL] [Abstract][Full Text] [Related]
20. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics.
Wen Z; Tallman MN; Ali SY; Smith PC
Drug Metab Dispos; 2007 Mar; 35(3):371-80. PubMed ID: 17151191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
